INVO Fertility, Inc. Stock or Unit Option Plan Expense
INVO Fertility, Inc. (IVF) reported Stock or Unit Option Plan Expense of $188.62 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2026-08-14
- INVO Fertility, Inc. stock or unit option plan expense for the quarter ending 2026-06-30 was $94.31K, a 694.20% increase year-over-year.
- INVO Fertility, Inc. stock or unit option plan expense for the quarter ending 2026-03-31 was $94.31K, a 33.48% increase year-over-year.
- INVO Fertility, Inc. stock or unit option plan expense for the quarter ending 2025-12-31 was $84.28K, a 36.80% decline year-over-year.
- INVO Fertility, Inc. stock or unit option plan expense for the quarter ending 2025-09-30 was $11.92K, a 82.74% decline year-over-year.
- INVO Fertility, Inc. stock or unit option plan expense for fiscal 2025 was $178.73K, a 47.85% decline from fiscal 2024.
- INVO Fertility, Inc. stock or unit option plan expense for fiscal 2024 was $342.73K, a 67.33% decline from fiscal 2023.
- INVO Fertility, Inc. stock or unit option plan expense for fiscal 2023 was $1.05M, a 35.10% decline from fiscal 2022.
- INVO Fertility, Inc. stock or unit option plan expense for fiscal 2022 was $1.62M.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month | Stock or Unit Option Plan Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $94.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $188.62K 10-Q · filed 2026-08-14 | $272.90K derived: sum of 3 quarters · filed 2026-08-14 | $284.82K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $94.31K 10-Q · filed 2026-06-22 | $178.59K derived: sum of 2 quarters · filed 2026-06-22 | $190.51K derived: sum of 3 quarters · filed 2026-06-22 | $202.38K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $84.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $96.20K derived: sum of 2 quarters · filed 2026-06-02 | $108.07K derived: sum of 3 quarters · filed 2026-08-14 | $178.73K 10-K · filed 2026-06-02 |
| 2025-09-30 | $11.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $23.79K derived: sum of 2 quarters · filed 2026-08-14 | $94.45K 10-Q · filed 2025-11-17 | $227.81K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $11.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $82.53K 10-Q · filed 2026-08-14 | $215.89K derived: sum of 3 quarters · filed 2026-08-14 | $284.92K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $70.66K 10-Q · filed 2026-06-22 | $204.01K derived: sum of 2 quarters · filed 2026-06-22 | $273.05K derived: sum of 3 quarters · filed 2026-06-22 | $342.08K derived: sum of 4 quarters · filed 2026-06-22 |
| 2024-12-31 | $133.36K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $202.39K derived: sum of 2 quarters · filed 2026-06-02 | $271.43K derived: sum of 3 quarters · filed 2026-06-02 | $342.73K 10-K · filed 2026-06-02 |
| 2024-09-30 | $69.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $138.07K derived: sum of 2 quarters · filed 2025-11-17 | $209.37K 10-Q · filed 2025-11-17 | $354.18K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $69.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $140.34K 10-Q · filed 2025-08-14 | $285.14K derived: sum of 3 quarters · filed 2025-08-14 | $536.70K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $71.30K 10-Q · filed 2025-05-20 | $216.10K derived: sum of 2 quarters · filed 2025-05-20 | $467.66K derived: sum of 3 quarters · filed 2025-05-20 | $794.58K derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | $144.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $396.36K derived: sum of 2 quarters · filed 2025-04-30 | $723.27K derived: sum of 3 quarters · filed 2025-04-30 | $1.05M 10-K · filed 2025-04-30 |
| 2023-09-30 | $251.56K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-19 | $578.47K derived: sum of 2 quarters · filed 2024-11-19 | $904.30K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $326.92K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-11-19 | $652.75K 10-Q/A · filed 2024-11-19 | ||
| 2023-03-31 | $325.83K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $1.62M 10-K/A · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |